Detalhe da pesquisa
1.
VRK1 phosphorylates and protects NBS1 from ubiquitination and proteasomal degradation in response to DNA damage.
Biochim Biophys Acta
; 1863(4): 760-9, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26869104
2.
Ras oncoprotein disrupts the TSH/CREB signaling upstream adenylyl cyclase in human thyroid cell.
J Cell Physiol
; 229(12): 2137-41, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24819468
3.
VRK1 Phosphorylates Tip60/KAT5 and Is Required for H4K16 Acetylation in Response to DNA Damage.
Cancers (Basel)
; 12(10)2020 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33076429
4.
VRK1 chromatin kinase phosphorylates H2AX and is required for foci formation induced by DNA damage.
Epigenetics
; 10(5): 373-83, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25923214
5.
Calcium/Calmodulin-dependent protein kinase II and its endogenous inhibitor α in medullary thyroid cancer.
Clin Cancer Res
; 20(6): 1513-20, 2014 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24449826
6.
Vaccinia-related kinase 1 (VRK1) confers resistance to DNA-damaging agents in human breast cancer by affecting DNA damage response.
Oncotarget
; 5(7): 1770-8, 2014 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24731990
7.
Interferon-γ inhibits integrin-mediated adhesion to fibronectin and survival signaling in thyroid cells.
J Endocrinol
; 215(3): 439-44, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23027608
8.
Calcium/calmodulin-dependent protein kinase II (CaMKII) phosphorylates Raf-1 at serine 338 and mediates Ras-stimulated Raf-1 activation.
Cell Cycle
; 11(11): 2100-6, 2012 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22592532
9.
The Ca2+-calmodulin-dependent kinase II is activated in papillary thyroid carcinoma (PTC) and mediates cell proliferation stimulated by RET/PTC.
Endocr Relat Cancer
; 17(1): 113-23, 2010 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-19903742